ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume -, Issue -, Pages n/a-n/a
Publisher
EMBO
Online
2013-12-28
DOI
10.1002/emmm.201303373
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma
- (2012) J P Baren et al. BRITISH JOURNAL OF CANCER
- Epithelial-to-Mesenchymal Transition Induced by TGF- 1 Is Mediated by Blimp-1-Dependent Repression of BMP-5
- (2012) M. Romagnoli et al. CANCER RESEARCH
- Immune predictors of cancer progression
- (2012) Benjamin Toh et al. IMMUNOLOGIC RESEARCH
- Potential of fluorescent metalloproteinase substrates for cancer detection
- (2011) Roopali Roy et al. CLINICAL BIOCHEMISTRY
- Basal Breast Cancer: A Complex and Deadly Molecular Subtype
- (2011) F. Bertucci et al. CURRENT MOLECULAR MEDICINE
- Confocal backscattering-based detection of leukemic cells in flowing blood samples
- (2011) Cherry Greiner et al. CYTOMETRY PART A
- ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth
- (2011) Roopali Roy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Assessment of the role of circulating breast cancer cells in tumor formation and metastatic potential using in vivo flow cytometry
- (2011) Derrick Hwu et al. JOURNAL OF BIOMEDICAL OPTICS
- Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17
- (2011) Thorsten Maretzky et al. Nature Communications
- Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients
- (2010) A. Pierce et al. GLYCOBIOLOGY
- Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
- (2010) Jo Eyles et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor Necrosis Factor- (TNF- ) Regulates Shedding of TNF- Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection
- (2010) J. W. Bartsch et al. JOURNAL OF NEUROSCIENCE
- Hypoxia-Inducible Factors and the Response to Hypoxic Stress
- (2010) Amar J. Majmundar et al. MOLECULAR CELL
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Role of ADAMs in Cancer Formation and Progression
- (2009) M. J. Duffy et al. CLINICAL CANCER RESEARCH
- VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
- (2009) Marja Lohela et al. CURRENT OPINION IN CELL BIOLOGY
- ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies
- (2009) Garrit Koller et al. CURRENT PHARMACEUTICAL DESIGN
- ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
- (2009) Sophia B. Lee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Regulated Expression of ADAM8 (a Disintegrin and Metalloprotease Domain 8) in the Mouse Ovary: Evidence for a Regulatory Role of Luteinizing Hormone, Progesterone Receptor, and Epidermal Growth Factor-Like Growth Factors1
- (2008) Venkataraman Sriraman et al. BIOLOGY OF REPRODUCTION
- VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis
- (2008) Lukas J.A.C. Hawinkels et al. EUROPEAN JOURNAL OF CANCER
- Distinct Functions of Natural ADAM-15 Cytoplasmic Domain Variants in Human Mammary Carcinoma
- (2008) J. L. Zhong et al. MOLECULAR CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started